Eiger BioPharmaceuticals Inc (EIGR)
Market Closed
17 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 73
0
0%
$
2.55M Market Cap
- P/E Ratio
- Div Yield
136,274 Volume
-48.58 Eps
$ 1.73
Previous Close Investors:
Want to track EIGR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eiger BioPharmaceuticals Inc (EIGR) Statistics
Valuation metrics
Market Cap 2.55M
Enterprise value 28.35M
Trailing P/E (ttm) -0.17
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.8
Price/Book (mrq) -0.87
Enterprise Value/Revenue 1.8
Enterprise Value/EBITDA -0.41
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 1.73
52-Week high 1.9
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 8 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.75%
Operating margin -4.55%
Operational effectiveness
Return on assets -1.93%
Return on equity -3.67%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -50.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 17.51
Total debt (mrq) -
Total Debt/Equity (mrq) -2.85
Current ratio (mrq) 0.71%
Book value per share (mrq) -9.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
